Published in Cancer Epidemiol on January 15, 2011
Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med (2013) 3.24
Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast Cancer Res (2013) 1.10
Comparing sensitivity and specificity of screening mammography in the United States and Denmark. Int J Cancer (2015) 1.04
Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network. Eur J Cancer (2013) 0.88
Mammographic density in birth cohorts of Danish women: a longitudinal study. BMC Cancer (2013) 0.83
Survival of women with breast cancer in central and northern Denmark, 1998-2009. Clin Epidemiol (2011) 0.81
Comparison of Danish dichotomous and BI-RADS classifications of mammographic density. Acta Radiol Short Rep (2014) 0.78
Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study. BMC Cancer (2016) 0.77
Risk of breast cancer after false-positive results in mammographic screening. Cancer Med (2016) 0.75
Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer (2012) 3.47
Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ (2005) 3.21
Occupation and cancer - follow-up of 15 million people in five Nordic countries. Acta Oncol (2009) 2.59
Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J (2006) 2.24
Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen (2012) 2.21
Position paper: breast cancer screening, diagnosis, and treatment in Denmark. Acta Oncol (2014) 2.04
Predicting the risk of a false-positive test for women following a mammography screening programme. J Med Screen (2007) 1.83
Incidence of cervical cancer after several negative smear results by age 50: prospective observational study. BMJ (2009) 1.81
Research recommendations for selected IARC-classified agents. Environ Health Perspect (2010) 1.73
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review. BMJ (2011) 1.72
Women's death in Scandinavia--what makes Denmark different? Eur J Epidemiol (2004) 1.69
Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study. Eur J Gastroenterol Hepatol (2007) 1.65
Determinants of participation in colorectal cancer screening with faecal occult blood testing. J Public Health (Oxf) (2009) 1.62
Occupation and bladder cancer among men in Western Europe. Cancer Causes Control (2003) 1.54
The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen (2012) 1.46
Has cytology become obsolete as a primary test in screening for cervical cancer? J Med Screen (2010) 1.42
[Overdiagnosis and overtreatment of breast cancer]. Ugeskr Laeger (2008) 1.40
[Degree of coverage of Danish health sciences research in the Science Citation Index, 1998]. Ugeskr Laeger (2004) 1.39
[Mammography screening without overdiagnosis]. Ugeskr Laeger (2004) 1.38
[Mammography screening--ideology contra science]. Ugeskr Laeger (2006) 1.36
Breast cancer incidence after the introduction of mammography screening: what should be expected? Cancer (2006) 1.35
Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries. Occup Environ Med (2014) 1.33
Estimating the benefits of mammography screening: the impact of study design. Epidemiology (2007) 1.32
Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe. Int J Cancer (2004) 1.31
Fertility pattern does not explain social gradient in breast cancer in denmark. Int J Cancer (2004) 1.30
Mammography screening in the county of Fyn. November 1993-December 1999. APMIS Suppl (2003) 1.27
Mammography screening in Denmark. Dan Med Bull (2011) 1.22
E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut (2010) 1.22
Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ (2013) 1.20
The diagnosis of breast implant rupture: MRI findings compared with findings at explantation. Eur J Radiol (2005) 1.19
Socioeconomic status and breast cancer in Denmark. Int J Epidemiol (2003) 1.19
Non-participation in screening: the case of cervical cancer in Denmark. Prev Med (2012) 1.17
Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer (2005) 1.15
Performance of clinical mammography: a nationwide study from Denmark. Int J Cancer (2006) 1.11
Women's patterns of participation in mammography screening in Denmark. Eur J Epidemiol (2006) 1.11
Lead time and down-staging in the survival of cervical cancer cases detected by screening. Prev Med (2013) 1.09
Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen (2012) 1.08
IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03
Socio-demographic determinants of participation in mammography screening. Int J Cancer (2008) 1.02
Alcohol drinking may increase risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control (2004) 1.01
Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay. PLoS One (2013) 1.00
Controlling sickness absence: a study of changes in the Danish sickness absence legislation since 1973. Health Policy (2007) 1.00
Patterns of cervical coinfection with multiple human papilloma virus types in a screening population in Denmark. Vaccine (2013) 1.00
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 human papillomavirus genotype microarray system. BMC Infect Dis (2014) 0.98
Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes. Acta Oncol (2006) 0.96
Participation in mammography screening among migrants and non-migrants in Denmark. Acta Oncol (2011) 0.96
European Commission's proposal for a council recommendation on cancer screening. BMJ (2003) 0.96
Colon cancer controls versus population controls in case-control studies of occupational risk factors. BMC Cancer (2004) 0.95
Introduction of human papillomavirus vaccination in Nordic countries. Vaccine (2011) 0.94
A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women. Cancer Causes Control (2006) 0.94
Frequency of cervical intraepithelial neoplasia treatment in a well-screened population. Int J Cancer (2011) 0.94
Birth weight, childhood body mass index, and height in relation to mammographic density and breast cancer: a register-based cohort study. Breast Cancer Res (2014) 0.94
Risk of breast cancer after false-positive test results in screening mammography. J Natl Cancer Inst (2012) 0.93
Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay. J Mol Diagn (2013) 0.93
Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe. Occup Environ Med (2010) 0.92
A model for determining the effect of mammography service screening. Acta Oncol (2005) 0.92
Process performance of cervical screening programmes in Europe. Eur J Cancer (2009) 0.92
Mortality of non-participants in cervical screening: Register-based cohort study. Int J Cancer (2013) 0.91
Trends in sickness absence in Denmark. Scand J Work Environ Health (2009) 0.90
Development of a Web-based concept for patients with ulcerative colitis and 5-aminosalicylic acid treatment. Eur J Gastroenterol Hepatol (2010) 0.90
Immunosuppression and risk of cervical cancer. Expert Rev Anticancer Ther (2013) 0.89
Breast cancer incidence, case-fatality and breast cancer mortality in Danish women using hormone replacement therapy--a prospective observational study. Int J Epidemiol (2005) 0.89
Participation behaviour following a false positive test in the Copenhagen mammography screening programme. Acta Oncol (2008) 0.89
Does educational level determine screening participation? Eur J Cancer Prev (2008) 0.88
Type of hormone therapy and risk of misclassification at mammography screening. Menopause (2011) 0.87
Existing data sources for clinical epidemiology: the Danish Quality Database of Mammography Screening. Clin Epidemiol (2013) 0.86
Performance indicators for participation in organized mammography screening. J Public Health (Oxf) (2012) 0.86
Performance of systematic and non-systematic ('opportunistic') screening mammography: a comparative study from Denmark. J Med Screen (2008) 0.85
Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review. Eur J Cancer Prev (2012) 0.85
Causes of death behind low life expectancy of Danish women. Scand J Public Health (2006) 0.84
Mammographic density in birth cohorts of Danish women: a longitudinal study. BMC Cancer (2013) 0.83
Seventeen-years overview of breast cancer inside and outside screening in Denmark. Acta Oncol (2012) 0.83
Performance of diagnostic mammography differs in the United States and Denmark. Int J Cancer (2010) 0.83
Hormone replacement therapy and risk of breast cancer: the role of progestins. Acta Obstet Gynecol Scand (2003) 0.83
Preparation and Administration of I-125 Labeled Seeds for Localization of Nonpalpable Breast Lesions. Curr Radiopharm (2016) 0.83
Socioeconomic status as determinant for participation in mammography screening: assessing the difference between using women's own versus their partner's. Int J Public Health (2010) 0.83
Why did the breast cancer lymph node status distribution improve in Denmark in the pre-mammography screening period of 1978-1994? Acta Oncol (2010) 0.82
The Spanish flu in Denmark. Scand J Infect Dis (2008) 0.82
The problem of false-positive human papillomavirus DNA tests in cervical screening. Curr Pharm Des (2013) 0.82
Register-based studies of cancer screening effects. Scand J Public Health (2011) 0.82